OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy
Oliver Schwartz, Katharina Vill, Michelle Pfaffenlehner, et al.
JAMA Pediatrics (2024) Vol. 178, Iss. 6, pp. 540-540
Closed Access | Times Cited: 23

Showing 23 citing articles:

2024 update: European consensus statement on gene therapy for spinal muscular atrophy
Janbernd Kirschner, G. Bernert, Nina Butoianu, et al.
European Journal of Paediatric Neurology (2024) Vol. 51, pp. 73-78
Open Access | Times Cited: 12

Präventive Neurologie – nie zu früh und nie zu spät
E. Schäffer, Ulrike Schara‐Schmidt, Marlena Schnieder
DGNeurologie (2025)
Closed Access | Times Cited: 1

Universal Newborn Screening for Spinal Muscular Atrophy
Maryam Oskoui, Tamara Dangouloff, Laurent Servais
JAMA Pediatrics (2024) Vol. 178, Iss. 6, pp. 520-520
Closed Access | Times Cited: 4

Systematic Review of Presymptomatic Treatment for Spinal Muscular Atrophy
Katy Cooper, Gamze Nalbant, Anthea Sutton, et al.
International Journal of Neonatal Screening (2024) Vol. 10, Iss. 3, pp. 56-56
Open Access | Times Cited: 4

Pushing the boundaries: future directions in the management of spinal muscular atrophy
Fiona Moultrie, Laura Chiverton, Isabel Hatami, et al.
Trends in Molecular Medicine (2025)
Open Access

Spinal muscular atrophy in the UK: the human toll of slow decisions
Laurent Servais, Tamara Dangouloff, Francesco Muntoni, et al.
The Lancet (2025) Vol. 405, Iss. 10479, pp. 619-620
Closed Access

A state-of-the-art review of registries in spinal muscular atrophy: A valuable resource for clinical research
Lakshmi Balaji, Michelle A. Farrar, Eppie M. Yiu, et al.
Journal of Neuromuscular Diseases (2025)
Closed Access

Newborn screening facilitates early theranostics and improved spinal muscular atrophy outcome: five-year real-world evidence from Taiwan
Chen‐Hua Wang, Ting‐Rong Hsu, Mei‐Ying Liu, et al.
Orphanet Journal of Rare Diseases (2025) Vol. 20, Iss. 1
Open Access

Thinking outside the box: A re-evaluation of Canadian recommended outcome measures in adult spinal muscular atrophy – report of a national consensus workshop
Colleen O’Connell, Xavier Rodrigue, Victoria Hodgkinson, et al.
Journal of Neuromuscular Diseases (2025)
Closed Access

TREAT: systematic and inclusive selection process of genes for genomic newborn screening as part of the Screen4Care project
Christina Saier, Stefaan Sansen, Joanne Berghout, et al.
Orphanet Journal of Rare Diseases (2025) Vol. 20, Iss. 1
Open Access

A systematic review on motor outcome measures in Congenital Myopathy
Matthew Woods, Gemma Fisher, Sarah Johnson, et al.
Neuromuscular Disorders (2025), pp. 105392-105392
Closed Access

Taldefgrobep Alfa and the Phase 3 RESILIENT Trial in Spinal Muscular Atrophy
Laurent Servais, Lindsey Lair, Anne M. Connolly, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10273-10273
Open Access | Times Cited: 2

Treatment strategies for patients with spinal muscular atrophy
Liesbeth De Waele, Laurent Servais
Expert Review of Neurotherapeutics (2024), pp. 1-3
Open Access | Times Cited: 2

Beyond Motor Neurons in Spinal Muscular Atrophy: A Focus on Neuromuscular Junction
Francesca Torri, Michelangelo Mancuso, Gabriele Siciliano, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7311-7311
Open Access | Times Cited: 1

Evaluating whole genome sequencing for rare diseases in newborn screening: evidence synthesis from a series of systematic reviews
Karoline Freeman, Jacqueline Dinnes, Bethany Shinkins, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Identification of Biochemical Determinants for Diagnosis and Prediction of Severity in 5q Spinal Muscular Atrophy Using 1H-Nuclear Magnetic Resonance Metabolic Profiling in Patient-Derived Biofluids
Afshin Saffari, Moritz Niesert, Claire Cannet, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12123-12123
Open Access | Times Cited: 1

Diagnosing missed cases of spinal muscular atrophy in genome, exome, and panel sequencing datasets
Ben Weisburd, Rakshya Sharma, Villem Pata, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Concerns About Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy—Reply
Oliver Schwartz, Astrid Pechmann, Janbernd Kirschner
JAMA Pediatrics (2024) Vol. 178, Iss. 9, pp. 955-955
Closed Access

Concerns About Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy
Min-Fang Cheng, Chia‐Hao Hsu
JAMA Pediatrics (2024) Vol. 178, Iss. 9, pp. 954-954
Closed Access

SMA-Screening für Neugeborene
Reinhold Kerbl
Monatsschrift Kinderheilkunde (2024) Vol. 172, Iss. 10, pp. 845-846
Closed Access

Comprehensive overview of the current state and impact of cohort studies in newborn screening
Priyanka Sangale, Atul N Khadse, Charushila Bhangale
MGM Journal of Medical Sciences (2024) Vol. 11, Iss. 3, pp. 533-542
Open Access

Gene therapy for spinal muscular atrophy: timing is key
Laurent Servais
The Lancet Regional Health - Europe (2024) Vol. 47, pp. 101112-101112
Open Access

SMA-Screening lohnt sich

Neonatologie Scan (2024) Vol. 13, Iss. 04, pp. 283-284
Closed Access

Investigating a Domain Adaptation Approach for Integrating Different Measurement Instruments in a Longitudinal Clinical Registry
Maren Hackenberg, Michelle Pfaffenlehner, Max Behrens, et al.
Biometrical Journal (2024) Vol. 67, Iss. 1
Open Access

Page 1

Scroll to top